We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNDA icon
1801
Vanda Pharmaceuticals
VNDA
$302M
-33,213
Closed -$499K
VOYA icon
1802
Voya Financial
VOYA
$9.19B
-4,665
Closed -$297K
VRNS icon
1803
Varonis Systems
VRNS
$5B
-46,592
Closed -$2.39M
VRNT
1804
DELISTED
Verint Systems
VRNT
-28,315
Closed -$1.29M
VRSK icon
1805
Verisk Analytics
VRSK
$25B
-110,881
Closed -$19.6M
VRT icon
1806
Vertiv
VRT
$105B
-70,831
Closed -$1.42M
VSEC icon
1807
VSE Corp
VSEC
$6.12B
-6,061
Closed -$239K
VST icon
1808
Vistra
VST
$47.4B
-850,053
Closed -$15M
VTGN icon
1809
VistaGen Therapeutics
VTGN
$12.8M
-94,282
Closed -$6.02M
VTR icon
1810
Ventas
VTR
$47.9B
-25,911
Closed -$1.38M
VUZI icon
1811
Vuzix
VUZI
$224M
-34,097
Closed -$868K
YARW
1812
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
-203
Closed -$1.25M
W icon
1813
Wayfair
W
$14.6B
-7,080
Closed -$2.23M
WABC icon
1814
Westamerica Bancorp
WABC
$1.37B
-9,022
Closed -$566K
WBS icon
1815
Webster Financial
WBS
$12.8B
-18,062
Closed -$994K
WDFC icon
1816
WD-40
WDFC
$3.15B
-1,231
Closed -$377K
WFG icon
1817
West Fraser Timber
WFG
$5.65B
-197,521
Closed -$14.2M
WGO icon
1818
Winnebago Industries
WGO
$909M
-26,549
Closed -$2.04M
WH icon
1819
Wyndham Hotels & Resorts
WH
$5.48B
-81,256
Closed -$5.67M
WHD icon
1820
Cactus
WHD
$5.44B
-13,934
Closed -$427K
WHR icon
1821
Whirlpool
WHR
$2.82B
-12,960
Closed -$2.86M
WIX icon
1822
WIX.com
WIX
$2.52B
-1,005
Closed -$281K
WMS icon
1823
Advanced Drainage Systems
WMS
$10.9B
-45,616
Closed -$4.72M
WNS
1824
DELISTED
WNS Holdings
WNS
-13,092
Closed -$948K
WOOF icon
1825
Petco
WOOF
$794M
-550,967
Closed -$12.2M

Similar funds

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.